StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.75−2.70 (-0.49%)

Close on Nov 17, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Chemed's revenue for the twelve months ending Sep 30, 2026 was $2.66B, up 5.2% year over year. For fiscal 2025 it was $2.53B, up 4.1% from the year before. Over ten years it grew 5.1% a year on average. The highest annual figure on record is $2.53B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.53B+4.1%
FY2024Dec 31, 2024$2.43B+7.4%
FY2023Dec 31, 2023$2.26B+6.1%
FY2022Dec 31, 2022$2.13B-0.2%
FY2021Dec 31, 2021$2.14B+2.9%
FY2020Dec 31, 2020$2.08B+7.3%
FY2019Dec 31, 2019$1.94B+8.7%
FY2018Dec 31, 2018$1.78B+7.0%
FY2017Dec 31, 2017$1.67B+5.7%
FY2016Dec 31, 2016$1.58B+2.2%
FY2015Dec 31, 2015$1.54B+6.0%
FY2014Dec 31, 2014$1.46B+3.0%
FY2013Dec 31, 2013$1.41B-1.2%
FY2012Dec 31, 2012$1.43B+5.5%
FY2011Dec 31, 2011$1.36B+5.9%
FY2010Dec 31, 2010$1.28B+7.6%
FY2009Dec 31, 2009$1.19B+3.6%
FY2008Dec 31, 2008$1.15B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$690.94M+10.6%
Q2 FY2026Jun 30, 2026$673.25M+8.8%
Q1 FY2026Mar 31, 2026$657.51M+1.6%
Q4 FY2025Dec 31, 2025$639.34M-0.1%
Q3 FY2025Sep 30, 2025$624.90M+3.1%
Q2 FY2025Jun 30, 2025$618.80M+3.8%
Q1 FY2025Mar 31, 2025$646.94M+9.8%
Q4 FY2024Dec 31, 2024$639.99M+9.2%
Q3 FY2024Sep 30, 2024$606.18M+7.4%
Q2 FY2024Jun 30, 2024$595.88M+7.6%
Q1 FY2024Mar 31, 2024$589.23M+5.2%
Q4 FY2023Dec 31, 2023$585.91M+7.2%
Q3 FY2023Sep 30, 2023$564.53M+7.2%
Q2 FY2023Jun 30, 2023$553.82M+4.2%
Q1 FY2023Mar 31, 2023$560.16M+5.6%
Q4 FY2022Dec 31, 2022$546.65M+1.0%
Q3 FY2022Sep 30, 2022$526.47M-2.3%
Q2 FY2022Jun 30, 2022$531.29M-0.2%
Q1 FY2022Mar 31, 2022$530.55M+0.6%
Q4 FY2021Dec 31, 2021$540.98M+1.4%
Q3 FY2021Sep 30, 2021$538.67M+2.0%
Q2 FY2021Jun 30, 2021$532.26M+6.0%
Q1 FY2021Mar 31, 2021$527.36M+2.2%
Q4 FY2020Dec 31, 2020$533.29M+2.1%
Q3 FY2020Sep 30, 2020$528.30M+9.9%
Q2 FY2020Jun 30, 2020$502.20M+6.0%
Q1 FY2020Mar 31, 2020$515.80M+11.6%
Q4 FY2019Dec 31, 2019$522.32M+14.2%
Q3 FY2019Sep 30, 2019$480.61M+8.2%
Q2 FY2019Jun 30, 2019$473.58M+7.2%
Q1 FY2019Mar 31, 2019$462.03M+5.2%
Q4 FY2018Dec 31, 2018$457.51M+6.8%
Q3 FY2018Sep 30, 2018$444.15M+6.4%
Q2 FY2018Jun 30, 2018$441.81M+6.4%
Q1 FY2018Mar 31, 2018$439.18M+8.2%
Q4 FY2017Dec 31, 2017$428.36M+6.2%
Q3 FY2017Sep 30, 2017$417.44M–
Q2 FY2017Jun 30, 2017$415.06M–
Q1 FY2017Mar 31, 2017$405.86M–
Q4 FY2016Dec 31, 2016$403.48M–

More Chemed figures

See a number that looks wrong?